Dokkyo Medical University · Faculty of Medicine · 血液・腫瘍内科 学内講師

Research keywordsInternal・medicine・Immunology・Cancer・research・Hematology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cells., Nakamura Fumi;Nakamura Yuka;Sasaki Ko;Yamazaki Ieharu;Imai Yoichi;Mitani Kinuko, Leukemia research, 156, 107738, 2025年06月23日2025 · 論文
• A CML Patient Carrying BCR::ABL1 Splicing Variants Did Not Experience Blast Crisis for 15 Years without Responding to Various TKIs., Nakamura Fumi;Sasaki Ko;Nannya Yasuhito;Iso Hisako;Nakamura Yuko;Imai Yoichi;Ogawa Seishi;Mitani Kinuko, Internal medicine (Tokyo, Japan), 64（3）, 455-458, 2024年09月07日2024 · 論文
• Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)., Nakamura Fumi;Seo Sachiko;Nannya Yasuhito;Ayabe Rika;Takahashi Wataru;Handa Tomoyuki;Arai Honoka;Iso Hisako;Nakamura Yuko;Nakamura Yuka;Sasaki Ko;Ichikawa Motoshi;Imai Yoichi;Ogawa Seishi;Mitani Kinuko, International journal of hematology, 118（3）, 388-393, 2023年03月17日2023 · 論文
• Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for NK-cell therapy in acute myeloid leukemia., Kaito Yuta;Sugimoto Emi;Nakamura Fumi;Tsukune Yutaka;Sasaki Makoto;Yui Shunsuke;Yamaguchi Hiroki;Goyama Susumu;Nannya Yasuhito;Mitani Kinuko;Tamura Hideto;Imai Yoichi, Haematologica, 2023年09月21日2023 · 論文

• Official profile
• ORCID